Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Neuroone Medical Technologies (NMTC) over the last 13 years, with Q4 2025 value amounting to -$1.4 million.

  • Neuroone Medical Technologies' Net Income towards Common Stockholders fell 18053.95% to -$1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.8 million, marking a year-over-year increase of 499.87%. This contributed to the annual value of -$3.6 million for FY2025, which is 7073.11% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Net Income towards Common Stockholders of -$1.4 million as of Q4 2025, which was down 18053.95% from -$1.6 million recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Net Income towards Common Stockholders peaked at $1.8 million during Q4 2024, and registered a low of -$3.5 million during Q1 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$2.8 million (2022), whereas its average is -$2.4 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 15337.45% in 2024, then crashed by 18053.95% in 2025.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Net Income towards Common Stockholders stood at -$2.8 million in 2021, then soared by 38.28% to -$1.7 million in 2022, then plummeted by 93.04% to -$3.3 million in 2023, then skyrocketed by 153.37% to $1.8 million in 2024, then plummeted by 180.54% to -$1.4 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$1.4 million for Q4 2025, versus -$1.6 million for Q3 2025 and -$1.5 million for Q2 2025.